Abstract-Combination of bradykinin with substance P exerted synergistic effects on vascular permeability and pain response in mouse paw.
Bradykinin has become of major interest recently as a chemical mediator of inflam mation and pain generation.
Previously, we have shown that bradykinin played an important role in formalin-induced pain response; substance P was also involved in the formation of the pain response (1). It is reported that substance P potentiated responses to bradykinin, serotonin, pro staglandin and ATP when tested on the dye-leakage response in rats (2). Bynke et al. demonstrated that injection of brady kinin into the vitreous chamber of the rabbit eye caused miosis and aqueous flare, and the response to bradykinin was reduced by substance P antagonists (3). They suggest that bradykinin causes miosis and aqueous flare at least partly through local release of neuronal substance P. This paper presents the results indicating that a mutual relation ship between bradykinin and substance P may be of importance in inflammation and pain sensation.
Male ddY strain mice (20-25 g) were given an injection of bradykinin, substance P or the mixture into a paw. To study the inflammatory reaction, a quantitative dye leakage technique was used. Five min after injection of pontamine blue (100 mg/kg, i.v.), the mediator was administered into the paw. Subsequently, 5 min after, the inflamed hindpaw was cut out, chopped into smaller pieces and placed into 4 ml of formamide. Twenty-four hr later, the amount of dye was measured according to the method of Gamse et al. (4). Pain threshold was deter mined by recording the durations (in sec) spent in licking or biting response against the inflamed forepaw during a 5 min period immediately after the mediator injection (5). In order to test whether substance P interacts with the bradykinin action, mice were pre treated with substance P-antagonist 10 min before and the denervation of sciatic nerve was carried out 48 hr before the experiment. The sciatic nerve of one side was cut in the midthigh under ether anesthesia. Statistical analysis was performed by Student's t-test. Figure 1 shows the effect of bradykinin in combination with substance P on pain response and vascular permeability. To study the effect of the combination, lower doses of bradykinin and substance P were chosen since it produced only a small response. Bradykinin (5.23 nmol) and substance P (3.70 nmol) exerted synergistic effects on pain response. The effect of bradykinin (340 pmol) with substance P (48 pmol) on vascular and vascular permeability. BK bradykinin, SP: substance P, BK+SP: mixture. In studying the pain response, bradykinin (5.23 nmol) and substance P (3.7 nmol) were used. In deter mining vascular permeability, bradykinin (340 pmol) and substance P (48 pmol) were used. Drugs were injected in a volume of 6.5 ,rel. *: P. 0.05. permeability was also greater than a simple summation of the two mediators. Denervation of the sciatic nerve and intravenous adminis tration of (D-Arg', D-Pro2, D-Trp7' 9, Leu" ) substance P (substance P-antagonist) reduced significantly bradykinin -induced vascular permeability (Fig. 2) .
From the facts that denervation of the sciatic nerve reduced dye-leakage induced by bradykinin (Fig. 2) , it is suggested that bradykinin may act partly via functioning of sensory nerves. Furthermore, bradykinin induced dye-leakage was also reduced by substance P-antagonist. Gamse et al. reported that the substance P content of the hind paw skin of rats was markedly decreased after cutting the saphenous nerve (4). These suggest that bradykinin acts by releasing a neurogenic mediator, possibly substance P. Fig. 2 . Effects of denervation of the sciatic nerve and substance P-antagonist on bradykinin-induced vascular permeability. C: saline control , SP-A: substance P-antagonist (0.1 mg/kg, i.v., 10 min before), S: sham operation, D: denervation of sciatic nerve (48 hr before) Bradykinin dose was 340 pmol. **: P 0 .01, ***: P -0.001.
We and Jancso et al. reported previously that there was a parallelism between the permeability and pain response in the process of neurogenic inflammation (1, 6). So it is reasonable that the synergistic effect of the drug combination on pain response was produced in the same manner as the effect on vascular permeability (Fig. 1 ) . Therefore, it may be that there is a similar mechanism of regulation by bradykinin and substance P on the process of pain sensation as well. Perhaps, noxious stimuli evoked the release of brady kinin and then bradykinin stimulated axon reflexive substance P release, and these two mediators acted together. 44, 45-49 (1977) 
